As shown in Figure 6A,B, phosphorylated ERK1/2, JNK1/2, and Akt were significantly decreased after treatment with different doses of picrasidine I in both NPC-039 and NPC-BM cells. This evidence concerns the gene MAPK3 and nasopharyngeal carcinoma.